The Aplastic Anaemia Gene Panel by NGS is an advanced molecular test that identifies genetic mutations associated with inherited or congenital forms of aplastic anaemia. Metropolis Healthcare performs this comprehensive analysis using next-generation sequencing to evaluate multiple bone marrow failure–related genes with high accuracy. The test aids in confirming diagnosis, differentiating inherited causes from acquired ones, and guiding treatment decisions. It also supports genetic counseling for families with a history of bone marrow failure disorders.
Price:
Rs. 21,000.00
Sample Type: EDTA BLOOD
Fasting Not Required
Notes:G0166
Frequently Asked Questions (FAQ's):
What does this test include at Metropolis Healthcare?
It includes NGS-based sequencing of genes involved in inherited bone marrow failure and aplastic anaemia.
How does Metropolis Healthcare perform this test?
DNA is extracted from an EDTA blood sample and analyzed using high-depth next-generation sequencing to detect relevant genetic variants.
Who should take this test at Metropolis Healthcare?
Individuals with unexplained pancytopenia, suspected inherited aplastic anaemia, or a family history of bone marrow failure disorders.
What sample is required at Metropolis Healthcare?
A routine EDTA blood sample is required for DNA extraction and genetic analysis.
How does this test help clinicians at Metropolis Healthcare?
It assists in distinguishing inherited causes from acquired aplastic anaemia and guides treatment strategies, including transplant planning.
Is any preparation needed before giving the sample at Metropolis Healthcare?
No fasting or special preparation is needed; only a standard blood collection is required.
How long does the test take at Metropolis Healthcare?
Turnaround time usually ranges from several days to a few weeks due to the complexity of sequencing.
When will I receive the report from Metropolis Healthcare?
Reports are provided as per the molecular diagnostics schedule, including detailed genetic interpretation.